NCAC-SOT Fall Webinar: Looking Forward After 19 Years of the Endocrine Disruptor Screening Program
Friday, September 18, 2015, 9:00 AM–12:00 Noon EDT
In the 1990s, a variety of chemicals were suspected of disrupting the endocrine system in animals. Based on scientific evidence, Congress approved the Food Quality Protection Act and Safe Drinking Water Act (SDWA) Amendments in August 1996 requiring the US EPA to initiate the Endocrine Disruptor Screening Program (EDSP) to screen pesticides, commercial chemicals and environmental contaminants for their potential effect on the endocrine systems of humans and wildlife. EDSP is a two-tiered screening process aimed at identifying chemicals and determining their potential to disrupt the endocrine systems of mammals, birds and fish.
Tier 1: US EPA will identify chemicals that have the potential to interact with the endocrine system.
Tier 2: US EPA will determine the endocrine-related effects caused by each chemical and obtain information about effects at various doses to enable subsequent risk assessments for each chemical.
US EPA announced the initial list of chemicals to be screened for their potential effects on the endocrine system (or Tier 1 testing) on April 15, 2009, and in November 2010, EPA issued a finalist (“List 1”) of chemicals for screening as well as draft policies and procedures for the EDSP. The second list of chemicals (as well as related policies and procedures) for screening under the SDWA (“List 2”) was issued on June 14, 2013 (with minor revisions in May 2014); however, US EPA currently does not have authorization from the White House Office of Management and Budget (OMB) to collect these data. On June 18, 2015, US EPA announced a plan for incorporating validated high-throughput assays and a computational model into the EDSP to screen chemicals for their ability to interact with the endocrine system. This proposed new method would serve as an alternative for three of the eleven current assays in the EDSP Tier 1 screening battery (estrogen receptor binding, estrogen receptor transactivation, uterotrophic). On July 30, 2015, US EPA released its reviews of the Tier 1 screening assay results for the first 52 pesticide chemicals (active and inert ingredients) in the EDSP, representing a major milestone of achievement for the almost 20-year-old program
This webinar provides a great opportunity to hear about the current status of the EDSP program from stakeholders involved with the program as well different perspectives on the future directions of the program.
|9:00 AM–9:05 AM|| ||Welcome/Procedures and Housekeeping Remarks|
|9:05 AM–9:30 AM|| ||Nineteen Years of the Endocrine Disruptor Screening Program: Where We Started and Where We Are Heading|
David J. Dix, PhD, Office of Science Coordination and Policy (OSCP), US EPA
|9:30 AM–10:00 AM|| ||Using High-Throughput Assays and Computational Tools for Endocrine Screening|
Patience Browne, PhD, Office of Science Coordination and Policy (OSCP), US EPA
|10:00 AM–10:30 AM|| ||Challenges and Opportunities for Wildlife Testing|
Caren Helbing, PhD, Professor Department of Biochemistry and Microbiology, University of Victoria, British Columbia, Canada
|10:30 AM–11:00 AM|| ||Concepts of Endocrinology: Issues Relevant to Endocrine Disruptor Screening|
Raphael Witorsch, PhD, Professor Emeritus Medical College of Virginia VCU and Consultant
|11:00 AM–11:30 AM|| ||Round Table Presentations—Application of Tox21/ToxCast and the Future of Regulatory Decision Making|
Industry Perspective: A Framework for Building Scientific Confidence in Tox21 and Risk21 Methods
Rick Becker, PhD, DABT, Senior Toxicologist American Chemistry Council
Academic Perspective: The Need for Evidence-Based Approaches
Thomas Hartung, MD, Director Center for Alternatives to Animal Testing (CAAT), Johns Hopkins University Bloomberg School of Public Health
Government Perspective: The Importance of Fit-for-Purpose Validation
Warren Casey, PhD, Director at National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods (NTP/NICEATM)
|11:30 AM–12:00 Noon|| ||Round Table Discussion—Application of Tox21/ToxCast and the Future of Regulatory Decision Making|
|12:00 Noon|| ||Closing Remarks|
New ALTEX: 2/2017
January 8-13, 2017
Various locations throughout Europe
Beginning April 2017
June 14-16, 2017
SAVE THE DATE:
10th World Congress on Alternatives and Animal Use in the Life Sciences
August 20-24, 2017